But the soon-to-be demerged consumer business will become Haleon British pharmaceutical giant GlaxoSmithKline has officially adopted GSK as its new moniker, essentially accepting that almost everyone already calls it by its three letter acronym anyway. But it is on its consumer business side that the biggest change will happen. That organisation, which is currently in
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.